Latest Market News

Way2VAT reported a 95% surge in Q1 FY26 revenue to $2.05 million, driven by its RBC acquisition and expanding client base, while preparing to launch an e-invoicing platform integrating AI-powered APAI technology.

Cleo Diagnostics has kicked off a staged manufacturing program with Bio-Techne to produce ovarian cancer test kits, moving from clinical sample collection to analytical validation and FDA submission preparation.

Minerals 260 has locked in a $220 million funding deal with Franco-Nevada, combining royalty and equity financing to fast-track its 4.5Moz Bullabulling Gold Project. Strong drilling results and accelerated project work underpin a development timeline targeting first production by end 2028.

Greatland Resources delivered a record $260 million cash build in the March 2026 quarter, underpinned by 82,723 ounces of gold production at a $2,056/oz AISC and a 150% increase in Telfer's Mineral Resource Estimate to 8 million ounces gold.

Imricor Medical Systems advanced FDA clearances and expanded clinical trials in Q1 CY26, positioning for commercial growth despite higher operating cash outflows.

Kincora Copper has kicked off a capital-efficient, sole-funded drilling campaign at its 100%-owned Condobolin gold-silver-base metals project in NSW’s Cobar Basin, targeting extensions to the high-grade Meritilga discovery and testing new geochemical and geophysical anomalies.

Singular Health boosted its US presence by deploying 500 additional 3DICOM MD® licenses to Provider Network Solutions, securing FDA 510(k) clearance for its cloud platform, and launching education pilots with Miami-Dade schools and Florida International University.

Predictive Discovery Limited (ASX:PDI) completed its merger with Robex Resources, propelling gold production to 48,178 ounces in Q1 2026 and setting sights on 400,000 ounces annual production by 2029.

Coronado Global Resources launched a structural reset targeting cash flow improvement, with Buchanan mine doubling EBITDA despite weak markets, while Logan mine was idled amid persistent High Vol challenges and a $160 million impairment is expected.

TMK Energy’s Gurvantes XXXV project hit a new daily gas production record exceeding 1,350 m³, confirming commercial desorption. The company secured $6 million in funding and regulatory approval to drill three new pilot wells and advance domestic gas use in Mongolia.

Vitrafy Life Sciences completed Phase II of its U.S. Military platelet cryopreservation study with strong results for a simplified no-wash process, accelerating commercial interest and progressing FDA device registration despite manufacturing delays.

American Tungsten & Antimony (ASX: AT4) has set up a Level 1 ADR program with Deutsche Bank, paving the way for its planned Nasdaq listing in Q2 2026 and opening U.S. dollar trading access for American investors.